Joe Rogan Experience #2210 - Calley Means & Casey Means, MD

The Joe Rogan Experience
02:22:41 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (307)

00:01 Podcast Introduction and Host Greeting chapter 1
00:01 Host Welcome and Podcast Context
00:33 Background of the Guest and Early Career chapter 2
00:33 Guest Introduction and Early Life in DC
01:03 Lobbying for Farm Industry Funding of NIH Panels
01:34 Lobbying for Food and Pharmaceutical Industries chapter 2
01:34 Lobbying for Food Industry Influence on Health Policy
02:05 Plausible Deniability and Corporate Messaging
02:38 Institutional Influence on Public Health Policies chapter 3
02:38 Industry Tactics to Promote Sugar Consumption
03:09 Mental Health Impact on Industry Professionals
03:39 Institutional Capture and Public Alarm
04:11 Political and Societal Implications of Corporate Capture chapter 2
04:11 Political Figures as Symbols of Institutional Failure
04:41 Health and Food Industry Collapse Concerns
05:12 Personal Journey from Medicine to Activism chapter 3
05:12 Statistical Evidence of Public Health Decline
05:43 Medical Career Path and Early Academic Work
06:13 Realization of Systemic Issues During Surgical Practice
06:43 Health Crisis Statistics and Trends chapter 3
06:43 Overview of American Health Disasters
07:14 Obesity, Diabetes, and Dementia Statistics
07:45 Cancer, Autism, Infertility, and Other Rising Conditions
08:17 Root Cause: Metabolic Dysfunction Explained chapter 3
08:17 Metabolic Disease as a Unifying Factor
09:19 Scientific Perspective on Metabolic Dysfunction
10:20 Education Gaps in Medical Training
10:51 Ecosystem Connection and Call to Action chapter 3
10:51 Human Health as a Mirror of Ecosystem Health
11:22 Interconnected Systems and the Need for Action
12:25 Mission Statement and Call to Decision-Making
12:55 Sponsored Segment: Healthy Dog Food chapter 3
12:55 Introduction to Farmer's Dog Product
13:26 Benefits of Human-Grade Fresh Food for Dogs
13:57 Promotional Offer and Call to Action
14:28 Public Health Data and Media Silence chapter 2
14:28 Data Availability vs. Public Awareness
15:00 Influence of Media and Corporate Interests on Health Messaging
15:31 The Diabetes–Alzheimer’s Connection chapter 2
15:31 Pre‑diabetes as a Root Cause for Alzheimer’s
16:02 Medical Education Focused on Disease Acceptance
16:33 Fragmented Healthcare System and Its Consequences chapter 2
16:33 Volume‑Based Incentives in American Healthcare
17:05 Specialist Silos and Patient Frustration
17:35 Rise of Neurodevelopmental and Mental Health Issues chapter 2
17:35 Surge in ADHD, Autism, and Other Neurodevelopmental Disorders
18:06 Mental Health Epidemic and SSRI Use
18:37 Hormonal Shifts Across the Lifespan chapter 1
18:37 Early Puberty and Hormonal Imbalances in Women
19:39 Collective Health Crisis as a Spiritual and Planetary Issue chapter 2
19:39 Collective Loss of Awe and Spiritual Connection
20:10 Call for a Consciousness‑Based Approach to Health
21:13 Environmental Estrogens and Early Puberty chapter 8
21:13 Political Reflection on Life Preservation
21:44 Early Puberty in Girls and Lack of Evidence
22:15 Plastics as Xenoestrogens
22:46 Microplastics in Human Organs and Placentas
23:18 Pesticides and Aromatase Activation
24:10 Visceral Fat as Estrogen Converter
24:50 Exogenous Estrogens in Birth Control and Environment
25:20 Sugar, Visceral Fat, and Feminization of Youth
25:58 Critique of Scientific Funding and Public Health Messaging chapter 5
25:58 Industry Funding of Research on Chronic Conditions
26:20 Critique of Randomized Controlled Trials in Nutrition
26:50 Wildlife vs. Human Health and Institutional Trust
27:21 Funding of Nutrition Schools by Food and Pharma Industries
27:51 Medical Board Oversight and Public Trust
28:22 Critique of Current Medical Focus on Vaccines and Metabolic Health chapter 2
28:22 Emphasis on Vaccine Exception Notes and Licensing Concerns
28:53 Discussion of Metabolic Health for Children and Obesity Trends
29:23 Personal Experience with Corporate Influence in Medicine chapter 2
29:23 Corporate Funding of Diabetes Research and Conflicts of Interest
29:54 Critique of Clinical Guidelines for Mental Health in Youth
30:25 Systemic Issues and the Rise of Siloed Care chapter 3
30:25 Challenges Faced by Doctors Who Question the System
30:57 Siloing of Medical Specialties and Its Economic Impact
31:27 Proposal to Reorient Clinical Guidelines Toward Metabolic Conditions
31:58 Economic Burden of Lifestyle Diseases on Medicaid chapter 2
31:58 Medicaid Spending on Preventable Lifestyle Diseases
32:30 Public Health Officials’ Opposition to Sunlight and Nutrition Advocacy
33:02 Call for Courageous Change in Public Health Policy chapter 3
33:02 Medical School Culture and the Need for Courageous Reform
33:33 Funding Conflicts in Medical Education and Research
34:03 Impact of Corporate Money on Clinical Guidelines and Litigation Risk
34:33 Personal Journey Through Medical Education and Advocacy chapter 1
34:33 Personal Reflection on Medical Training and the Need for Cellular Health Education
35:04 Medical Education Gaps and Nutrition Deficiencies chapter 2
35:04 Lack of Nutrition Curriculum in Medical Schools
35:35 Conflicts of Interest and Food Industry Influence
36:06 Environmental Toxins and Chronic Disease Links chapter 3
36:06 Impact of Plastic, Pesticides, and Endocrine Disruptors
36:39 Physical Activity as Disease Prevention
37:11 Sleep Deprivation and Metabolic Risk
37:42 Sleep, Light, and Circadian Health chapter
38:12 Systemic Challenges for Physicians and Tribalism chapter 3
38:12 Medical Errors as a Leading Cause of Death
38:44 The Role of Spirituality and Collective Action in Health
39:15 Bipartisan Vision for Human and Planetary Health
39:46 Historical Foundations of Modern Medicine chapter 4
39:46 Public Trust Erosion During COVID-19
40:17 Historical Flexner Report and Its Legacy
41:20 John D. Rockefeller’s Influence on Medical Education
42:21 Early 20th Century Medical Milestones and Siloed Care
42:52 Medical Miracles and the Birth of Chronic Disease Management chapter 3
42:52 Antibiotics and Early Medical Miracles
43:23 Birth Control Pill as the First Long‑Term Medication
43:54 Shift to Chronic Disease Management in the 1970s
44:25 Pharmaceutical Influence on Mental Health and Lifestyle Diseases chapter 3
44:25 Valium and Psychiatric Medications in the 1970s
44:55 Cigarette Companies Acquire Food Businesses
45:27 Creation of the Ultra‑Processed Food Pyramid
45:58 Cigarette Companies Enter the Food Industry and Weaponize Nutrition chapter 1
46:28 Chemical Load in American Food vs. Europe
47:30 Regulatory Gaps and Chemical Exposure in American Food chapter 3
47:30 Regulatory Oversight and the GRAS System
48:00 Food Chemicals vs. Drugs – The Mass Drugging Argument
48:31 Glyphosate Litigation and Scientific Corruption
49:02 The Hidden Dangers of Unregulated Food Additives chapter 2
49:02 Challenges of Studying Synergistic Chemical Effects
49:32 Historical Roots of Processed Food and Military Needs
50:03 Industrial Food Manipulation and Feminist Narratives chapter 2
50:03 Weaponizing Feminist Movement for Corporate Gain
50:35 Rise of Ultra-Processed Foods and Corn Syrup
51:07 Fructose Science and Human Hunger Mechanisms chapter 2
51:07 Fructose as a Hunger Hormone in Bears
51:38 Industrial Production of High-Fructose Corn Syrup
52:09 Legislative Immunity for Pharmaceutical Companies chapter 1
52:09 Historical Vaccine Litigation and Corporate Immunity
53:11 Fructose Corn Syrup and Satiety Disruption chapter 2
53:11 Fructose Corn Syrup’s Impact on Satiety
53:43 Uric Acid, Mitochondrial Dysfunction, and Behavioral Outcomes
54:14 Mitochondrial Dysfunction, Uric Acid, and Behavioral Effects chapter 2
54:14 Comparing Fructose in Food vs. Natural Sources
55:50 Synergistic Toxicity and Limitations of Isolated Studies
56:53 Limitations of Double-Blind Studies in Toxicology chapter 1
56:53 Challenges of Double-Blind Trials for Food and Lifestyle Interventions
57:25 Science Integrity and the Role of Intuition chapter 2
57:25 Critique of Scientific Publishing Practices
57:56 The Dangers of Questioning Intuition in Science
58:28 Parenting, Intuition, and Societal Expectations chapter 3
58:28 Intuitive Parenting vs. Societal Pressure
58:58 Frustration of Parents Facing New Rules
59:29 Alzheimer’s as a Chronic Disease Trend
59:59 Chronic Disease Trends and the Rise of Alzheimer’s chapter 1
1:00:01 The All‑Time High of Multiple Chronic Conditions
1:00:31 Metabolic Dysfunction as a Root Cause of Alzheimer’s chapter 8
1:00:31 Metabolic Biomarkers and Disease Prevention
1:01:01 Linking Diabetes, Depression, and Alzheimer’s Risk
1:01:32 The Need for a Paradigm Shift in Chronic Disease Research
1:02:02 Chronic Disease Growth and Healthcare Economics
1:02:33 Metabolic Dysfunction as the Core of Alzheimer’s
1:03:05 Brain Energy and Systemic Metabolism Connection
1:03:35 Pre‑diabetes Prevalence and Early Onset Dementia
1:04:06 Youth Metabolic Health and Alzheimer’s Risk
1:04:36 Metabolic Foundations of Brain Health chapter 1
1:04:36 Brain Protective Plaques as Symptom Management
1:05:07 Alzheimer’s and Metabolic Biomarkers chapter 1
1:05:07 Metabolic Health and Alzheimer’s Risk Factors
1:06:07 Systemic Incentives and Public Health Policy chapter 5
1:06:07 Key Metabolic Hallmarks Affecting the Brain
1:07:08 Alzheimer’s Research Critiques and Corruption Allegations
1:08:42 Economic Incentives Driving Health Policy
1:09:44 Obesity Legislation and Medicare/Medicaid Impact
1:11:17 Critique of One-Size-Fits-All Drug Approaches
1:12:20 Obesity Data Presentation and Investor Reaction chapter 2
1:12:20 Presentation of Obesity Trends at JP Morgan Conference
1:12:50 Investor Reaction to Obesity Data
1:13:33 Critique of Pharmaceutical Policy and Legislative Influence chapter 4
1:13:33 Criticism of OIC Prescription Practices
1:14:11 Discussion of Legislative Influence on Obesity Treatment
1:14:33 Linking COVID-19 Mortality to Metabolic Health
1:15:03 Comparative Healthcare Spending and Outcomes in Italy vs. US
1:15:36 Public Health System vs. Food Industry Dynamics chapter 3
1:15:36 Industry Capture and Congressional Influence
1:15:56 Bipartisan Advocacy for Metabolic Health Policy
1:16:26 Congressional Staff Influence on Healthcare Legislation
1:17:30 Personal Motivation and Advocacy Efforts chapter 2
1:17:30 Personal Story of Maternal Cancer and Motivation for Advocacy
1:18:12 Engagement with Political Figures to Address Childhood Health Issues
1:19:02 RFK and Trump Alignment Discussion chapter 3
1:19:02 RFK’s Historical Impact and Vision
1:19:33 Personal Encounter with RFK in Austin
1:20:05 Connecting RFK and Trump on Health Issues
1:20:37 Health and Institutional Capture Themes chapter 3
1:20:37 Discussion of Diabetes and Obesity in Children
1:21:07 Broader Health Crisis and Nuclear Threats
1:21:39 Voter Perception of Institutional Capture
1:22:11 Political Power and Industry Influence chapter 4
1:22:11 Industry Influence on Policy and Leadership
1:23:13 Potential Coalition of Influencers
1:23:44 Agriculture and Health System Transformation
1:24:15 AI for Vaccine Misinformation Removal
1:24:46 Future Policy Directions and AI Intervention chapter 3
1:25:16 Pharma and Academic Funding Dynamics
1:25:48 Incremental vs Radical Health Policy Debate
1:26:20 Coordinated Opposition and Machine Behind Politics
1:26:50 Freedom of Speech and Media Control chapter 2
1:26:50 Scripted Narratives and Institutional Capture
1:27:21 Hope in Independent Media Amid Suppression
1:27:53 Information Manipulation by Pharma and Lobbying chapter 2
1:27:53 Global Awakening and the Role of Social Platforms
1:29:25 Pharma Advertising Budgets and News Influence
1:29:56 Food Industry Influence on Research and Policy chapter 3
1:29:56 Harvard Studies as Tools of Corporate Power
1:30:27 Lobbying and Conflicted Research Funding
1:30:57 Food Industry Lobbying Against Nutritional Science
1:31:28 Political Movements, Public Trust, and Health Reform chapter 2
1:31:28 Public Awareness and the Need for Consciousness Shift
1:32:58 Political Alliances and Calls to Action on Health Reform
1:34:33 Frustration of Voters and the Populist Uprising chapter 2
1:34:33 Voter Frustration and Corruption Outrage
1:35:06 Pharmaceutical Corruption as a Political Issue
1:36:38 Proposed Leadership Changes in Health Agencies chapter 2
1:36:38 Reforming Health Agencies with New Leadership
1:37:11 Unbiased Science and NIH Funding Priorities
1:38:44 Grassroots Focus vs. Money in Politics chapter 2
1:38:44 Grassroots Power vs. Money in Politics
1:39:15 Public Engagement and Political Momentum
1:40:48 Challenges of Executive Leadership and Industry Pushback chapter 2
1:40:48 Industry Pushback on Executive Decisions
1:41:20 Preparing for Leadership Amid Complex Challenges
1:41:52 Policy Foundations and Funding Reform chapter 3
1:41:52 Executive Order on Foundational Research
1:42:22 Disallowing Industry Funding for Nutrition Guidelines
1:42:53 Critique of Healthcare Profit Motives
1:43:56 Healthcare Incentives and Pharmaceutical Pricing chapter 2
1:43:56 Price Setting and Innovation Concerns
1:44:37 Leadership Accountability in Health Policy
1:45:00 Public Health Advocacy and Grassroots Momentum chapter 4
1:45:00 Parental Concerns and Public Health Narrative
1:45:08 Grassroots Momentum for Metabolic Health
1:45:30 Systemic Barriers to Healthy Eating
1:46:01 Food Industry Response to Consumer Demand
1:46:33 Nutrition Policy, Food Industry Reform, and Agricultural Impact chapter 4
1:46:33 Agricultural Policy and Regenerative Practices
1:47:06 Impact on Farmers and Public Health Outcomes
1:47:37 Cultural Shift Toward Healthy Living
1:48:08 Momentum for Systemic Change
1:48:39 Health System Critique and Personal Motivation chapter 3
1:48:39 Motivation to Improve Population Health
1:49:09 Critique of Current Food and Healthcare Subsidies
1:49:41 Founding a Company to Issue Medical Necessity Letters
1:50:12 Introduction of Medical Necessity Letters for Lifestyle Changes chapter 2
1:50:12 Legal Basis for Prescribing Lifestyle Changes
1:50:44 Education of Congress and HSA Funds Utilization
1:51:15 Policy Advocacy and Economic Incentives for Healthy Living chapter 3
1:51:15 Comparing Medication vs Lifestyle Outcomes in Depression
1:51:46 European Models for PCOS and Metabolic Health
1:52:16 Challenges in U.S. Medical Practice for PCOS Treatment
1:53:18 Chronic Disease Management and Patient Empowerment chapter 2
1:53:18 Advocating HSA/FSA Use for Preventive Health
1:54:21 Critique of Chronic Disease Medication Overuse
1:55:53 Critique of Food and Pharmaceutical Subsidies chapter 5
1:55:53 Statins, Heart Disease, and Public Health Choices
1:56:24 Farm Bill Subsidies and Ultra‑Processed Foods
1:57:26 Political Timing of Farm Bill Extensions
1:58:28 Conservative Think Tanks and Lobbying Strategies
1:59:01 Healthcare Industry Influence on Media and Policy
2:00:03 Lobbying, Media Influence, and Healthcare Industry Power chapter 2
2:00:03 Medical Misinformation and Vaccine Debate
2:01:07 Personal Experience in Surgery and Industry Ethics
2:03:10 Surgical Oncology and the Hammer Analogy chapter 2
2:03:10 Surgical Oncology Department Experience
2:03:43 Systemic Issues in Healthcare Funding
2:04:14 Value‑Based Care and Its Pitfalls chapter 3
2:04:14 Value‑Based Care Concept
2:04:45 Industry Influence on Quality Metrics
2:05:15 Medication‑Based Outcome Reporting
2:05:46 Regulatory Influence on Agriculture and Food Safety chapter 3
2:05:46 EPA and Pesticide Regulation Debate
2:06:16 Executive Leadership for Systemic Reform
2:06:46 Legislative Priorities and Bipartisan Support
2:07:17 Systemic Change Through Executive Leadership chapter 3
2:07:17 Systems Thinking in Healthcare
2:07:47 Reorienting Incentives for Disease Reversal
2:08:18 Public Access to Health Information
2:08:48 Public Information and Cultural Shifts in Health & Food chapter 3
2:08:48 Regenerative Agriculture vs. Industrial Food Systems
2:09:20 Economic Barriers to Sustainable Food
2:09:51 Congressional Decision‑Making and Food Policy
2:10:22 Challenges of Pediatric Obesity Treatment chapter 2
2:10:22 Weekly Injection Regimen for Children
2:10:54 Pharmaceutical Focus vs. Root Causes
2:11:55 Critique of Pharmaceutical Approaches and Lifestyle Factors chapter 1
2:11:55 Cost and Accessibility of Treatment Options
2:12:30 Bipartisan Potential for Chronic Disease Reversal chapter 1
2:12:30 Political Framing of Lifestyle Interventions
2:13:04 Cultural and Technological Distractions Impacting Children chapter 4
2:13:04 Executive Leadership and Moral Clarity
2:14:07 Media and Cultural Distractions on Children
2:14:38 Impact of Technology and Screen Time
2:15:10 Gender Roles and Parenting Priorities
2:15:41 Societal Pressures on Parenting and Food Choices chapter 2
2:15:41 Food Quality and Ultra-Processed Diets
2:16:41 Societal Pressures on Work and Family Balance
2:17:46 Spiritual Awakening and Personal Responsibility chapter 3
2:17:46 Living in Fear vs. Spiritual Potential
2:18:17 Body as Temple and Environmental Responsibility
2:18:47 Political Tactics for Consciousness Elevation
2:19:21 Critique of Corporate Influence on Health chapter 2
2:19:21 Corporate Money and Diffusion of Responsibility
2:20:22 Critique of Corporate Capture and Ideology
2:20:53 Introducing Empowerment Tools and Resources chapter 2
2:20:53 Introducing Levels.com for Metabolic Health
2:21:24 Using HSA/FSA Funds for Root Cause Interventions
2:21:55 Call to Action for Health Policy Engagement chapter 1
2:21:55 Engaging Congress on Health Policy

Transcript

Loading transcript...